|
|
|
Insider
Information: |
Borges Luis |
Relationship: |
Chief Scientific Officer |
City: |
South San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
321,423 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$2,465,744 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
321,423 |
|
|
Total
Value |
$2,465,744 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Five Prime Therapeutics Inc |
FPRX |
SVP, Research |
2017-03-01 |
64,888 |
2016-09-08 |
0 |
Premium* |
|
Century Therapeutics, Inc. |
IPSC |
Chief Scientific Officer |
2023-04-03 |
256,535 |
2023-02-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
12 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
IPSC |
Century Therapeutics, Inc... |
Chief Scientific Officer |
|
2023-04-03 |
4 |
OE |
$1.03 |
$7,676 |
D/D |
7,452 |
256,535 |
0 |
- |
|
IPSC |
Century Therapeutics, Inc... |
Chief Scientific Officer |
|
2023-03-23 |
4 |
S |
$3.55 |
$55,369 |
D/D |
(15,597) |
249,083 |
0 |
- |
|
IPSC |
Century Therapeutics, Inc... |
Chief Scientific Officer |
|
2023-03-23 |
4 |
OE |
$1.03 |
$227,558 |
D/D |
220,930 |
264,680 |
0 |
- |
|
IPSC |
Century Therapeutics, Inc... |
Chief Scientific Officer |
|
2023-03-22 |
4 |
S |
$3.72 |
$244,640 |
D/D |
(65,698) |
43,750 |
0 |
- |
|
IPSC |
Century Therapeutics, Inc... |
Chief Scientific Officer |
|
2023-03-22 |
4 |
OE |
$1.03 |
$67,669 |
D/D |
65,698 |
109,448 |
0 |
- |
|
IPSC |
Century Therapeutics, Inc... |
Chief Scientific Officer |
|
2023-03-21 |
4 |
S |
$3.77 |
$239,870 |
D/D |
(63,616) |
43,750 |
0 |
- |
|
IPSC |
Century Therapeutics, Inc... |
Chief Scientific Officer |
|
2023-03-21 |
4 |
OE |
$1.03 |
$65,524 |
D/D |
63,616 |
107,366 |
0 |
- |
|
IPSC |
Century Therapeutics, Inc... |
Chief Scientific Officer |
|
2023-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
43,750 |
43,750 |
0 |
- |
|
FPRX |
Five Prime Therapeutics I... |
SVP, Research |
|
2017-03-01 |
4 |
D |
$44.77 |
$809,621 |
D/D |
(18,084) |
64,888 |
0 |
- |
|
FPRX |
Five Prime Therapeutics I... |
SVP, Research |
|
2017-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
12,656 |
82,972 |
0 |
- |
|
FPRX |
Five Prime Therapeutics I... |
SVP, Research |
|
2017-01-03 |
4 |
D |
$48.60 |
$63,472 |
D/D |
(1,306) |
70,316 |
0 |
- |
|
FPRX |
Five Prime Therapeutics I... |
SVP, Research |
|
2016-09-08 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
71,622 |
0 |
- |
|
12 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|